These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1036972)

  • 21. Qualitative and quantitative changes of nucleoli in lymphocytes of cancer patients during cytembena or cyclophosphamide therapy.
    Matĕjková E; Vlastiborová A
    Neoplasma; 1973 May; 20(5):517-23. PubMed ID: 4800661
    [No Abstract]   [Full Text] [Related]  

  • 22. Preliminary results with the new cytostatic Penberol in ovarian carcinoma.
    Novotná J; Andrysek O
    Neoplasma; 1980; 27(1):77-82. PubMed ID: 7374860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chemotherapy of ovarian cancer].
    Pickel H; Lahousen M
    Gynakol Rundsch; 1980 Jun; 20 Suppl 2():77-83. PubMed ID: 6260600
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of platinum plus cyclophosphamide in patients with epithelial ovarian cancer.
    Tangjitgamol S; Mamusirinitaya S; Leelahakorn S; Thawaramara T; Pataradool K; Suekwatana P; Sittidilokratna K
    J Med Assoc Thai; 2005 Sep; 88(9):1172-81. PubMed ID: 16536101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comprehensive therapy of ovarian neoplasms. 3. Our results of chemotherapy in progressive ovarian neoplasms].
    Dvorák O
    Zentralbl Gynakol; 1972 Mar; 94(10):330-2. PubMed ID: 4113133
    [No Abstract]   [Full Text] [Related]  

  • 26. Ifosfamide treatment of advanced ovarian cancer.
    Yazigi R; Wild R; Madrid J; Arraztoa J
    Obstet Gynecol; 1984 Feb; 63(2):163-6. PubMed ID: 6694809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results obtained with chemotherapy of carcinoma colli uteri (author's transl)].
    Slavík V; Dvorák O
    Cesk Gynekol; 1976 Dec; 41(10):731. PubMed ID: 1036975
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclophosphamide "metronomic" chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer.
    Samaritani R; Corrado G; Vizza E; Sbiroli C
    BMC Cancer; 2007 Apr; 7():65. PubMed ID: 17433113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Directed chemotherapy of ovarian cancer].
    Dvorák O; Andrýsek O; Stránská E
    Cesk Gynekol; 1969 Mar; 34(3):123-6. PubMed ID: 5770712
    [No Abstract]   [Full Text] [Related]  

  • 30. [New developments in the chemotherapy of ovarian cancer (author's transl)].
    Brunner KW; Goldhirsch A; Joss R
    Schweiz Rundsch Med Prax; 1981 Apr; 70(18):809-14. PubMed ID: 7243721
    [No Abstract]   [Full Text] [Related]  

  • 31. [Results obtained with chemotherapy of endometrial cancer (author's transl)].
    Chmelík V; Dvorák O
    Cesk Gynekol; 1976 Dec; 41(10):727-8. PubMed ID: 1036974
    [No Abstract]   [Full Text] [Related]  

  • 32. Advanced ovarian cancer: therapy with radiation and cyclophosphamide in a random series.
    Johnson CE; Decker DG; Van Herik M; Mussey E; Malkasian GD; Jorgensen EO
    Am J Roentgenol Radium Ther Nucl Med; 1972 Jan; 114(1):136-41. PubMed ID: 4550548
    [No Abstract]   [Full Text] [Related]  

  • 33. [Endoxan in ovarian cancer].
    Campodónico I; Soldati A; Rodríguez A
    Rev Chil Obstet Ginecol; 1974; 39(3):87-9. PubMed ID: 4620179
    [No Abstract]   [Full Text] [Related]  

  • 34. [Polymer-drug complexes in the treatment of extensive ovarian cancer].
    Novikova EG; Borisov VI; Dmitriev DG; Zel'vin BM; Karseladze AI; Shchitkov KG; Li AD
    Sov Med; 1991; (11):27-9. PubMed ID: 1767307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian carcinoma treated with cyclophosphamide (Endoxan).
    Hsii FP; Jayaratnam FJ; Siang SC
    Singapore Med J; 1968 Sep; 9(3):195-7. PubMed ID: 5710986
    [No Abstract]   [Full Text] [Related]  

  • 36. [Report on the management of advanced ovarian cancer using Endoxan (Asta) and cyclophosphamide preparations].
    Dvorák O; Spirová M
    Zentralbl Gynakol; 1967 Jul; 89(26):940-5. PubMed ID: 5587033
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of ovarian cancer in the renal transplant recipient with cyclophosphamide used as an immunosuppressive and antineoplastic agent.
    Vincent F; Michel M; Marrast AC; Bensousan TA; Glotz D; Duboust A
    Transplant Proc; 1995 Aug; 27(4):2432. PubMed ID: 7652865
    [No Abstract]   [Full Text] [Related]  

  • 38. Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.
    Barlow JJ; Piver MS
    Cancer Treat Rep; 1976 May; 60(5):527-33. PubMed ID: 1086714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chemotherapeutic treatment of advanced ovarian carcinoma. Preliminary results of the Piedmont-Liguria Cooperative Group].
    Conte PF; Rosso R; Bruzzone M; Sertoli MR; Rubagotti A; Santi L; Carnino F; Cottini M; Mossetti C; Gatti M
    Minerva Ginecol; 1984 Apr; 36(4):213-6. PubMed ID: 6547773
    [No Abstract]   [Full Text] [Related]  

  • 40. [Determination of the nucleolar coefficient in lymphocytes in chemotherapeutically treated patients with ovarian carcinoma].
    Jandrová A; Laurová L; Skoda V; Trnka V
    Zentralbl Bakteriol Orig B; 1975; 91(9):549-51. PubMed ID: 1189808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.